Creotech Instruments (WAR:CRI) ROCE %: -19.54% (As of Mar. 2026)

What is Creotech Instruments ROCE %?

Creotech Instruments WAR:CRI -2.28% 73 ROCE % is -19.54% as of Mar. 2026. GuruFocus rates WAR:CRI with a GF Score™ of 73/100 and a GF Value™ of zł752.35 (Fairly Valued). The stock has 6 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Creotech Instruments's annualized ROCE % for the quarter that ended in Mar. 2026 was -19.54%.

Creotech Instruments (WAR:CRI) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Creotech Instruments ROCE % Related Terms

Creotech Instruments ROCE % Historical Data

* Premium members only.

The historical data trend for Creotech Instruments's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Creotech Instruments ROCE % Chart

Creotech Instruments Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROCE %

Get a 7-Day Free Trial

2.09

-17.71

-15.13

-14.87

15.51

Creotech Instruments Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial															8.82	3.01	-15.76	57.53	-19.54

73GF Score

Creotech Instruments SA WAR:CRI

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Creotech Instruments ROCE % Calculation

Creotech Instruments's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	26.971	/	( ( (162.328 - 29.637)	+	(332.687 - 117.622) )	/ 2 )
	=	26.971	/	( (132.691	+	215.065)	/ 2 )
	=	26.971	/	173.878
	=	15.51 %

Creotech Instruments's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	-39.38	/	( ( (332.687 - 117.622)	+	(307.11 - 119.104) )	/ 2 )
	=	-39.38	/	( ( 215.065	+	188.006 )	/ 2 )
	=	-39.38	/	201.5355
	=	-19.54 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of -19.54% mean?

Creotech Instruments (WAR:CRI) has a ROCE % of -19.54% as of Mar. 2026.

Is Creotech Instruments' ROCE % too high?

Creotech Instruments' current ROCE % is -19.54%. Overall, Creotech Instruments has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does Creotech Instruments' ROCE % compare to GE and RTX?

Creotech Instruments' ROCE % of -19.54% can be compared against companies in the Aerospace & Defense industry. The industry median ROCE % is 6.29. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for an Aerospace & Defense company?

The median ROCE % among Aerospace & Defense companies is 6.29, based on 350 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Aerospace & Defense industry, the median ROCE % is 6.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Creotech Instruments's current ROCE % is -19.54%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Creotech Instruments stock overvalued right now?

Based on GuruFocus' analysis, Creotech Instruments (WAR:CRI) is currently considered Fairly Valued. The stock's GF Value™ is zł752.35, compared to a current price of zł727.00 — trading 3.4% below its estimated fair value. The current ROCE % is -19.54%. Creotech Instruments' overall GF Score™ is 73/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Creotech Instruments (WAR:CRI), the current ROCE % is -19.54% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Creotech Instruments (WAR:CRI) Overvalued in 2026?

Based on GuruFocus' analysis, Creotech Instruments stock appears to be undervalued. The current stock price of zł727.00 is trading 3.4% below its estimated GF Value™ of zł752.35. GuruFocus considers Creotech Instruments to be Fairly Valued.

Key valuation signals for WAR:CRI:

ROCE %: -19.54%
GF Value™: zł752.35 vs. price of zł727.00 (3.4% below fair value)
GF Score™: 73/100 with 6 warning signs

No single metric tells the full story. See the WAR:CRI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Creotech Instruments Business Description

Industry Industrials Aerospace & Defense

Comparable Companies GE RTX BA XPAR:AIR LSE:RR.XPAR:SAF LMT HWM GD RKLB NOC LSE:BA.TDG XTER:RHM LHX XPAR:HO XKRX:329180 XTAE:ESLT SHSE:600150 HEI.A

Other Exchanges 5OB:Germany

Address Gen. L. Okulickiego 7/9, Piaseczno, POL, 05-500

Website https://www.creotech.pl

Creotech Instruments SA is a provider of advanced space technologies, specialized electronics, and hardware with global applications in areas such as quantum computers, quantum cryptography, quantum physics, and high energy physics laboratories. Its five primary business segments are: NewSpace dedicated to developing a satellite platform and its components; Earth Observation dedicated to developing Earth Observation systems and UAV technology (Unmanned Aerial Vehicle); Science dedicated to developing specialized electronics and components for quantum computers and time synchronization systems; Production dedicated to the manufacture of electronics; ESA Projects dedicated chiefly to projects carried in partnership with or/and commissioned by the European Space Agency (ESA).

73GF Score

Get the complete analysis for WAR:CRI

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł727.00

Price

zł752.35

GF Value

View WAR:CRI Analysis

See ROCE % data for all stocks →